- Home
- BEP vs AXSM Comparison
BEP vs AXSM Comparison
Compare BEP & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEP | AXSM |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 9.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BEP | AXSM |
|---|---|---|
| Price | $30.18 | $156.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $34.30 | ★ $209.18 |
| AVG Volume (30 Days) | ★ 561.8K | 493.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.36 | $58.34 |
| Revenue Next Year | N/A | $54.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.29 | $86.99 |
| 52 Week High | $32.78 | $191.50 |
Technical Indicators
Market Signals| Indicator | BEP | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 31.90 |
| Support Level | $29.25 | $148.14 |
| Resistance Level | $32.75 | $191.13 |
| Average True Range (ATR) | 0.85 | 4.67 |
| MACD | -0.21 | -1.37 |
| Stochastic Oscillator | 29.23 | 9.19 |
Price Performance
Historical ComparisonAbout BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.